Na Liu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Vascular Endothelial Growth Factor

Acute Kidney Injury

Long Noncoding Rna

Signaling Pathway

Top Venues

Journal of cellular and molecular medicine

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

The Journal of pathology

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Chao Yu, Jinhua Tang, Jianjun Yu, Yanjin Wang, Na Liu, Zheng Dong, Shougang Zhuang
JMJD3 activation contributes to renal protection and regeneration following acute kidney injury in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (7) (2024)
Chao Yu, Jinhua Tang, Jianjun Yu, Yanjin Wang, Na Liu, Zheng Dong, Shougang Zhuang
JMJD3 activation contributes to renal protection and regeneration following acute kidney injury in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (7) (2024)
Xun Zhou, Hui Chen, Yan Hu, Xiaoyan Ma, Jinqing Li, Yingfeng Shi, Min Tao, Yi Wang, Qin Zhong, Danying Yan, Shougang Zhuang, Na Liu
Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization. Cell death & disease 14 (4) (2023)
Chao Yu, Tingting Li, Jialu Li, Binbin Cui, Na Liu, George Bayliss, Shougang Zhuang
Inhibition of polycomb repressive complex 2 by targeting EED protects against cisplatin-induced acute kidney injury. Journal of cellular and molecular medicine 26 (14) (2022)
Yingfeng Shi, Jinqing Li, Hui Chen, Yan Hu, Lunxian Tang, Yi Wang, Xiujuan Zang, Xiaoyan Ma, Guansen Huang, Xun Zhou, Min Tao, Zexin Lv, Si Chen, Andong Qiu, Shougang Zhuang, Na Liu
Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF-1α-dependent signaling pathway. The Journal of pathology 258 (2) (2022)
Min Tao, Xiaoyan Ma, Xiaoling Pi, Yingfeng Shi, Lunxian Tang, Yan Hu, Hui Chen, Xun Zhou, Lin Du, Yongbin Chi, Shougang Zhuang, Na Liu
Prevalence and related factors of hyperuricaemia in Shanghai adult women of different ages: a multicentre and cross-sectional study. BMJ open 11 (9) (2021)
Feng Liu, Chao Yu, Huan Qin, Shenglei Zhang, Lu Fang, Yi Wang, Jun Wang, Binbin Cui, Susie Hu, Na Liu, Shougang Zhuang
Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis. Journal of cellular and molecular medicine (2021)
Yingfeng Shi, Yan Hu, Binbin Cui, Shougang Zhuang, Na Liu
Vascular endothelial growth factor-mediated peritoneal neoangiogenesis in peritoneal dialysis. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2021)
Guansen Huang, Yi Wang, Yingfeng Shi, Xiaoyan Ma, Min Tao, Xiujuan Zang, Yinghui Qi, Cheng Qiao, Lin Du, Lili Sheng, Shougang Zhuang, Na Liu
The prognosis and risk factors of baseline high peritoneal transporters on patients with peritoneal dialysis. Journal of cellular and molecular medicine 25 (18) (2021)
Yi Wang, Yingfeng Shi, Min Tao, Shougang Zhuang, Na Liu
Peritoneal fibrosis and epigenetic modulation. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 41 (2) (2020)
Yingfeng Shi, Min Tao, Yi Wang, Xiujuan Zang, Xiaoyan Ma, Andong Qiu, Shougang Zhuang, Na Liu
Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis. The Journal of pathology 250 (1) (2019)
Jinfang Bao, Yingfeng Shi, Min Tao, Na Liu, Shougang Zhuang, Weijie Yuan
Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy. Clinical science (London, England : 1979) 132 (21) (2018)